Meeting
2022 ASCO Genitourinary Cancers Symposium
Impact of provider education on prostate cancer genetic counseling referrals.
Authors
Emily Moody
University of Utah, Salt Lake City, UT
Emily Moody , McCall Larson , Samantha Greenberg , Taylor Jump , Mckenzie Bell , Jesse Gygi , Lisa Garcia , Desiree Dougherty , Brock O Neil , Steven C Lynch , Derrick S. Haslem , David Michael Gill
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 59)
DOI
10.1200/JCO.2022.40.6_suppl.059
Abstract #
59
Poster Bd #
C5
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Perceptions of emerging PARP inhibitor (PARPi) data among practicing oncologists in prostate cancer.
First Author: Nicholas Moffett
Poster
2022 ASCO Annual Meeting
Alliance A031902 (CASPAR): A randomized, phase (ph) 3 trial of enzalutamide with rucaparib/placebo in first-line metastatic castration-resistant prostate cancer (mCRPC).
First Author: Arpit Rao
Poster
2022 ASCO Annual Meeting
Reversion mutations in BRCA1 or BRCA2 genes: Resistant mechanism(s) in patients treated with platinum-based agents or poly (ADP-ribose) polymerase(PARP) inhibitors.
First Author: Sourat Darabi
Poster
2022 ASCO Genitourinary Cancers Symposium
Clinical utility of next-generation sequencing for prostate cancer in the context of a changing treatment landscape.
First Author: Jacqueline R. Griffin